Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Hamill currently holds 136,381 shares of SAVIENT PHARMACEUTICALS INC (SVNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Hamill has been a net seller of SVNT stock. They have purchased $0 and sold $3.0K worth of shares.
John Hamill's most recent insider trade was on Nov 10, 2015, when they sold 136,381 shares at $0.00 per share.
John Hamill serves as Executive at SAVIENT PHARMACEUTICALS INC (SVNT). They have executed 8 insider transactions totaling $3.0K over their tenure at the company.
John Hamill holds the position of Executive at SAVIENT PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
John Hamill has shown a selling trading pattern, with $0 in total purchases and $3.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Hamill was on Sep 24, 2012, when they purchased $292.0K worth of SVNT shares. This transaction involved 100,000 shares at $2.92 per share.
John Hamill currently owns 136,381 shares of SAVIENT PHARMACEUTICALS INC (SVNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Hamill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Hamill has 8 Form 4 filings on record as an insider at SAVIENT PHARMACEUTICALS INC.
Set alerts for John Hamill and 40,000+ other insiders.